Catalyst Wire Dossier Catalyst Wire Dossier

Latanoprost 0.005%

latanoprost · Pfizer
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Latanoprost 0.005%, covering 2008-01-02 to 2022-11-07. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Preserved and Preservative-free Latanoprost 0.005% in Primary Open Angle Glaucoma and Ocular Hypertensive Patients, at Guinness Eye Centre, Lagos. [Phase 4]

See pricing